NASDAQ:SLGC

SomaLogic - SLGC Stock Forecast, Price & News

$2.90

-0.07 (-2.36%)

(As of 09/30/2022 12:00 AM ET)

Add

Compare

Today's Range: $2.90
▼
$3.06
50-Day Range: $2.90
▼
$5.15
52-Week Range: $2.85
▼
$14.72

Volume: 1.44 million shs
Average Volume: 1.22 million shs
Market Capitalization: $532.01 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $12.20

SomaLogic MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 320.7% Upside
$12.20 Price Target
Short Interest: Healthy
9.09% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 1.27
Based on 2 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Decreasing
From ($0.50) to ($0.56) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.15 out of 5 stars

Business Services Sector

194th out of 336 stocks

Commercial Physical Research Industry

11th out of 16 stocks

3.5

Analyst's Opinion

Consensus Rating
SomaLogic has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $12.20, SomaLogic has a forecasted upside of 320.7% from its current price of $2.90.
Amount of Analyst Coverage
SomaLogic has only been the subject of 1 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
9.09% of the float of SomaLogic has been sold short.
Short Interest Ratio / Days to Cover
SomaLogic has a short interest ratio ("days to cover") of 6.5.
Change versus previous month
Short interest in SomaLogic has recently decreased by 6.26%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
SomaLogic does not currently pay a dividend.
Dividend Growth
SomaLogic does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for SLGC.

2.9

News and Social Media Coverage

News Sentiment
SomaLogic has a news sentiment score of 1.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.51 average news sentiment score of Business Services companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for SomaLogic this week, compared to 1 article on an average week.
Search Interest
Only 1 people have searched for SLGC on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days.
MarketBeat Follows
Only 1 people have added SomaLogic to their MarketBeat watchlist in the last 30 days. This is a decrease of -88% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, SomaLogic insiders have not sold or bought any company stock.
Percentage Held by Insiders
12.90% of the stock of SomaLogic is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
59.29% of the stock of SomaLogic is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Earnings Growth
Earnings for SomaLogic are expected to decrease in the coming year, from ($0.50) to ($0.56) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of SomaLogic is -3.49, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of SomaLogic is -3.49, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
SomaLogic has a P/B Ratio of 0.86. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About SomaLogic (NASDAQ:SLGC) Stock

SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. The company's SOMAmers/SomaScan technology enables researchers to analyze various types of biological samples for protein biomarker signatures, which can be utilized in drug discovery and development. Its SomaScan's biomarker discoveries help in diagnostic applications in various areas of diseases, including cardiovascular and metabolic disease, nonalcoholic steatohepatitis, wellness, and others. The company also provides SomaSignal research use only and laboratory-developed tests. It serves research and clinical customers with a focus on pharmaceutical and biotechnology companies, and academic research institutions, as well as facilitates drug development, analysis of clinical trials, and new human biology insights by assessing protein-protein and protein-gene networks. The company was incorporated in 1999 and is headquartered in Boulder, Colorado.

Receive SLGC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SomaLogic and its competitors with MarketBeat's FREE daily newsletter.

SLGC Stock News Headlines

September 26, 2022 | finance.yahoo.com

SomaLogic's Chief Medical Officer Steve Williams honored with C-Suite Award by the Denver Business Journal

September 24, 2022 | americanbankingnews.com

Analyzing SomaLogic (SLGC) & The Competition

September 23, 2022 | americanbankingnews.com

Head-To-Head Survey: SomaLogic (SLGC) vs. Its Rivals

September 14, 2022 | finance.yahoo.com

SomaLogic to Present at the Capital One Spatial Biology & Proteomics Summit

September 2, 2022 | finance.yahoo.com

SomaLogic, Inc. (SLGC) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

August 31, 2022 | finance.yahoo.com

SomaLogic to Present at Morgan Stanley 20th Annual Global Healthcare Conference

August 16, 2022 | sg.finance.yahoo.com

SomaLogic Reports Second Quarter 2022 Financial Results

August 16, 2022 | seekingalpha.com

SomaLogic, Inc. (SLGC) CEO Roy Smythe on Q2 2022 Results - Earnings Call Transcript

July 28, 2022 | nasdaq.com

We Think SomaLogic (NASDAQ:SLGC) Can Afford To Drive Business Growth

July 26, 2022 | finance.yahoo.com

SomaLogic acquires DNA nanotechnology leader Palamedrix to develop the next-generation SomaScan® Assay

June 14, 2022 | finance.yahoo.com

What Type Of Shareholders Own The Most Number of SomaLogic, Inc. (NASDAQ:SLGC) Shares?

June 13, 2022 | seekingalpha.com

SomaLogic inks license deal with OncoHost to develop precision cancer diagnostics

June 13, 2022 | finance.yahoo.com

SomaLogic Announces License Agreement with OncoHost for the Development of Precision Cancer Diagnostics

June 1, 2022 | apnews.com

SomaLogic Announces June Conference Participation

May 22, 2022 | finance.yahoo.com

Insiders purchases in SomaLogic, Inc. (NASDAQ:SLGC) last year yet to pay off, remain down US$212k despite recent gains

May 17, 2022 | benzinga.com

SomaLogic (NASDAQ:SLGC), Analyst Ratings, Price Targets, Predictions

May 13, 2022 | nasdaq.com

Comparing Bitcoin Versus SomaLogic Reveals New Low

May 13, 2022 | seekingalpha.com

SomaLogic, Inc. (SLGC) CEO Roy Smythe on Q1 2022 Results - Earnings Call Transcript

April 29, 2022 | nz.finance.yahoo.com

SomaLogic (NASDAQ:SLGC) investors are sitting on a loss of 49% if they invested a year ago

April 21, 2022 | uk.finance.yahoo.com

SomaLogic to Announce First Quarter 2022 Financial Results

April 12, 2022 | morningstar.com

Major journal publishes landmark proteomics study demonstrating development of an unprecedented new clinical cardiovascular risk test

April 12, 2022 | seekingalpha.com

SomaLogic Inc: A Biopharmaceutical Company With An Excellent Upside

March 29, 2022 | ca.finance.yahoo.com

SomaLogic Reports Fourth Quarter and Full Year 2021 Financial Results

March 21, 2022 | finance.yahoo.com

SomaLogic to provide 210 million protein measurements to EPIC researchers to better understand and predict cancer development

March 14, 2022 | nasdaq.com

Will Insiders Be Tempted To Buy More SLGC At The New 52-Week Low?

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive SLGC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SomaLogic and its competitors with MarketBeat's FREE daily newsletter.

SLGC Company Calendar

Today: 10/01/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Commercial physical research
Sub-Industry: N/A
Sector: Business Services
Current Symbol: NASDAQ:SLGC
CUSIP: N/A
CIK: 1837412
Web: ii.cmlifesciencesspac.com
Phone: 303-625-9000
Fax: N/A
Employees: 320
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $12.20
High Stock Price Forecast: $16.00
Low Stock Price Forecast: $9.00
Forecasted Upside/Downside: +320.7%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 4 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.83)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-87,550,000.00
Net Margins: -114.46%
Pretax Margin: -114.46%
Return on Equity: -16.76%
Return on Assets: -14.61%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 18.86
Quick Ratio: 18.26

Sales & Book Value

Annual Sales: $81.63 million
Price / Sales: 6.52
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $3.37 per share
Price / Book: 0.86

Miscellaneous

Outstanding Shares: 183,450,000
Free Float: 159,788,000
Market Cap: $532.01 million
Optionable: Not Optionable
Beta: 1.53

Key Executives

Dr. Roy Smythe M.D. (Age 60)
CEO & Director
Comp: $1.27M

Mr. Shaun M. Blakeman (Age 44)
Chief Financial Officer
Comp: $316.49k

Dr. Jason Cleveland Ph.D.
Chief Technology Officer

Dr. Nebojsa Janjic Ph.D. (Age 61)
Chief Science Officer

Dr. Stephen A. Williams BS (Age 62)
MB, Ph.D., Chief Medical Officer

Mr. Todd Johnson
Exec. VP of Diagnostics Bus. Unit

Mr. Adam Taich
Exec. VP of Life Sciences Bus. Unit

Ms. Lauren Glaser
Sr. VP of Investor Relations & Strategic Fin.

Mr. Byron D. Hewett (Age 66)
Advisor

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

SLGC Stock - Frequently Asked Questions

Should I buy or sell SomaLogic stock right now?: 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for SomaLogic in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" SLGC shares.
View SLGC analyst ratings or view top-rated stocks.
What is SomaLogic's stock price forecast for 2022?: 4 brokers have issued twelve-month price targets for SomaLogic's shares. Their SLGC share price forecasts range from $9.00 to $16.00. On average, they expect the company's share price to reach $12.20 in the next twelve months. This suggests a possible upside of 320.7% from the stock's current price.
View analysts price targets for SLGC or view top-rated stocks among Wall Street analysts.
How have SLGC shares performed in 2022?: SomaLogic's stock was trading at $11.64 at the beginning of the year. Since then, SLGC shares have decreased by 75.1% and is now trading at $2.90.
View the best growth stocks for 2022 here.
What guidance has SomaLogic issued on next quarter's earnings?: SomaLogic issued an update on its FY 2022 earnings guidance on Monday, September, 12th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $80.00 million-$90.00 million, compared to the consensus revenue estimate of $106.95 million.

What is SomaLogic's stock symbol?: SomaLogic trades on the NASDAQ under the ticker symbol "SLGC."
How do I buy shares of SomaLogic?: Shares of SLGC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is SomaLogic's stock price today?: One share of SLGC stock can currently be purchased for approximately $2.90.
How much money does SomaLogic make?: SomaLogic (NASDAQ:SLGC) has a market capitalization of $532.01 million and generates $81.63 million in revenue each year. The company earns $-87,550,000.00 in net income (profit) each year or ($0.83) on an earnings per share basis.
How many employees does SomaLogic have?: The company employs 320 workers across the globe.
How can I contact SomaLogic?: SomaLogic's mailing address is 667 MADISON AVENUE, NEW YORK NY, 10065. The official website for the company is ii.cmlifesciencesspac.com. The company can be reached via phone at 303-625-9000 or via email at investors@somalogic.com.

This page (NASDAQ:SLGC) was last updated on 10/2/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

SomaLogic - SLGC Stock Forecast, Price & News

SomaLogic MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows